Identification of Novel Genes Associated with Alginate Production in Pseudomonas aeruginosa Using Mini-himar1 Mariner Transposon-mediated Mutagenesis

Summary

Here we describe a protocol using the mini-himar1 mariner transposon-mediated mutagenesis for generating a high-density insertion mutant library to screen, isolate and identify novel alginate regulators in the prototypic Pseudomonas aeruginosa strain PAO1.

Abstract

Pseudomonas aeruginosa is a Gram-negative, environmental bacterium with versatile metabolic capabilities. P. aeruginosa is an opportunistic bacterial pathogen which establishes chronic pulmonary infections in patients with cystic fibrosis (CF). The overproduction of a capsular polysaccharide called alginate, also known as mucoidy, promotes the formation of mucoid biofilms which are more resistant than planktonic cells to antibiotic chemotherapy and host defenses. Additionally, the conversion from the nonmucoid to mucoid phenotype is a clinical marker for the onset of chronic infection in CF. Alginate overproduction by P. aeruginosa is an endergonic process which heavily taxes cellular energy. Therefore, alginate production is highly regulated in P. aeruginosa. To better understand alginate regulation, we describe a protocol using the mini-himar1 transposon mutagenesis for the identification of novel alginate regulators in a prototypic strain PAO1. The procedure consists of two basic steps. First, we transferred the mini-himar1 transposon (pFAC) from host E. coli SM10/λpir into recipient P. aeruginosa PAO1 via biparental conjugation to create a high-density insertion mutant library, which were selected on Pseudomonas isolation agar plates supplemented with gentamycin. Secondly, we screened and isolated the mucoid colonies to map the insertion site through inverse PCR using DNA primers pointing outward from the gentamycin cassette and DNA sequencing. Using this protocol, we have identified two novel alginate regulators, mucE (PA4033) and kinB (PA5484), in strain PAO1 with a wild-type mucA encoding the anti-sigma factor MucA for the master alginate regulator AlgU (AlgT, σ²²). This high-throughput mutagenesis protocol can be modified for the identification of other virulence-related genes causing change in colony morphology.

Introduction

The ability of the opportunistic, Gram-negative pathogen Pseudomonas aeruginosa to overproduce alginate is a major factor in its ability to establish a biofilm. The overproduction of alginate is a phenotype often referred to as mucoidy. The isolation of mucoid colonies from the sputa of individuals afflicted with cystic fibrosis (CF) is indicative of a chronic infection, and is directly associated with an overall decline in the patient's health¹. Currently, it is understood that the regulation and production of alginate in P. aeruginosa primarily occurs at two operons. The first is the alginate biosynthetic operon, which contains 12 genes (algD-alg8-alg44-algK-algE-algG-algX-algL-algI-algJ-algF-algA) that are responsible for the synthesis and export of the alginate polymer across the periplasm to the extracellular environment^2-5. The second operon is a cluster of genes beginning with the alternative sigma factor algU/T and continuing with mucA, mucB, and mucD. AlgU/T is a positive regulator, while mucAB-D are classified as negative regulators of alginate production^6-8. Additionally, transcriptional regulators, such as AlgB, AlgQ, AlgR, and RpoN, as well as post-transcriptional and post-translational modification by catabolite repression control, kinase activity (KinB) and intramembrane proteolysis, have also been shown to be involved in alginate regulation^9-14.

The mini-himar1 transposon vector known as pFAC was originally created in Dr. Mekalanos' lab at Harvard Medical School¹⁵. The pFAC plasmid consists of a transposable element flanked by two inverted repeats of 27 bps and a gentamycin resistance cassette in the middle (aacC1: 534 bp), a gene encoding the hyperactive mariner transposase¹⁶, and a gene encoding β-lactamase (bla) (Figure 1) . Sequence information for the transposable element of pFAC is available at the GenBank accession number: DQ366300¹³. In pFAC, there is a multiple cloning site (MCS) behind the aacC1 gene which is used for the identification of the chromosomal insertion site using inverse PCR. One major advantage with using the mini-himar1 transposon is no specific host factors are required for transposition (mutagenesis). Additionally, there is high abundance of the TA dinucleotide insertion sites found throughout the genome of P. aeruginosa. For example, TA dinucleotide insertion sites occurs 94,404 and 100,229 times in the PAO1 (6,264,404 bps, GenBank accession number NC_002516.2) and PA14 (6,537,648 bps; GenBank access number NC_008463) genomes, respectively. Because of the abundance of TA dinucleotide in the genome, mini-himar1 transposon can cause the high-density and random mutagenesis, which is particularly suitable for the analysis of virulence genes and the genes that are highly regulated. Theoretically, the mini-himar1 transposon can insert into any nonessential gene within the genome of P. aeruginosa. This provides approximately 18 TA insertion sites per open reading frame in the PAO1 genome.

Here, we describe a protocol using mini-himar1 transposon-mediated mutagenesis to identify novel regulators of mucoidy in P. aeruginosa. More specifically, we biparentally conjugated the pFAC vector containing a mini-himar1 transposon from E. coli SM10/λpir into the nonmucoid prototrophic strain PAO1. After the transposon is integrated in the genome, the recipient strain is cultured on Pseudomonas isolation agar (PIA) containing triclosan which inhibits the growth of E. coli. Thus, a library of mutants of P. aeruginosa can be selected by the growth on PIA plate supplemented with gentamycin and the presence of the mucoid phenotype. Note, a true transposon-mediated vs. an integration mutant will have a gentamycin resistant and carbenicillin-sensitive phenotype. In this study, approximately 80,000 insertion mutants of PAO1 were isolated through four separate conjugations. We then screened for mucoid isolates, and determined the site of insertion by restriction enzyme digestion, ligation and inverse PCR. We performed Southern blot analysis using the gentamycin resistance cassette as a probe to see the number of insertion per genome. We determined that more than 90% of mutants obtained per conjugation using this protocol had only a single copy of the himar1 in the genome and displayed the gentamycin resistant and carbenicillin-sensitive phenotype. A total of 32 mucoid isolates were identified, 22 of them were mapped to different loci of the P. aeruginosa PAO1 chromosome. This rate of insertion provides adequate coverage to identify several novel regulators of alginate overproduction.

Protocol

1. Preparation of Bacterial Strains and Biparental Conjugation

1. Inoculate E. coli SM10/λpir/pFAC in 5 ml of Luria Broth (LB) supplemented with 15 µg/ml of gentamycin and place in a shaking incubator overnight at 37 °C.
2. Inoculate P. aeruginosa strain PAO1 in 5 ml of LB, and place in a shaking incubator overnight at 42 °C.
3. Measure OD₆₀₀ of overnight cultures and mix equal amounts of PAO1 and E. coli pFAC such that the final volume is between 1-1.4 ml.
4. Centrifuge mixture at 6,000 x g for 5 min.
5. Meanwhile, dry LB plates for conjugation: leave plates open in incubator at 37 °C for 10-15 min.
6. Remove all but 50 µl of supernatant from cell mixture.
7. Resuspend the cell pellet in the remaining 50 µl of supernatant and pipette onto a dry LB plate in one compact droplet.
8. Carefully place the plate in a fume hood to dry (IMPORTANT Note: Do not let cells spread over the plate, this will significantly decrease the efficiency of the conjugation).
9. Once the droplet is dry, invert the LB plate and incubate at 37 °C for 4-6 hr.
10. While the cell mixture is incubating, prepare large (150 O.D. x 15 mm) PIA plates with 300 µg/ml of gentamycin. Before use, remove any residual moisture by placing in an incubator at 37 °C for 15-20 min.
11. After the incubation of the cell mixture is complete, collect the cells using a sterile inoculation loop and in a microcentrifuge tube containing 1 ml LB and vortex, or pipette, to mix thoroughly.
12. Spread the cells evenly onto the large PIA plates contain 300 µg/ml gentamycin. (IMPORTANT: For this step, it is best to add increasing volumes of the cell mixture to separate plates (e.g. Plate 1: 10 µl, Plate 2: 50 µl, Plate 3: 100 µl, Plate 4: 500 µl, etc.).
13. Incubate overnight at 37 °C.

2. Detection and Isolation of Mucoid Colonies

1. Remove plates from incubator and examine for mucoid colonies.
2. Isolate a single mucoid colony and streak for isolation on small plates (100 O.D. x 10 mm) with PIA and 300 µg/ml of gentamycin.
3. Incubate overnight at 37 °C.
4. Repeat step 2.2 on the previous overnight culture.
5. Repeat steps 2.2-2.4 two more times to determine stability of the mucoid isolate.
6. After final isolate step, inoculate 4.5 ml of LB with a single mucoid colony and incubate in shaker overnight at 37 °C.
7. Next day, label 3 microcentrifuge tubes for each mucoid mutant.
8. Prepare two 1.25 ml aliquots of overnight culture into 2 tubes for genomic DNA extraction and identification of the transposon insertion site (see Protocol 3).
9. Additionally, archive each mucoid mutant by pipetting 1 ml overnight culture into an appropriately-labeled cryovial containing an equal volume of 10% skim milk. Store at -86 °C.

3. gDNA Restriction Digestion and Ligation

1. Extract gDNA from the mucoid mutant using any preferred method (e.g. phenol-chloroform, spin column, etc.).
2. Determine the concentration of the gDNA, digest a total of 2 µg with 1 µl of the restriction endonuclease SalI, 0.5 µl of bovine serum albumin, 5 µl of SalI enzyme buffer (100 mM NaCl, 50 mM Tris-HCl, 10 mM MgCl₂, 1 mM Dithiothrietol (DTT), pH 7.9 at room temperature), and the appropriate volume of dH₂O to achieve a total volume of 50 µl.
3. Digest DNA overnight at 37 °C. (IMPORTANT: Depending on the efficiency of the restriction enzyme, it may be necessary to add an additional 1 µl to the overnight digest and incubate at 37 °C for 1-2 hr. This is in addition to the overnight digest.)
4. Purify the digested DNA using any preferred method (e.g. agarose gel purification, spin columns) and elute with 25 µl of buffer.
5. Ligate the digested DNA by mixing 11 µl of purified DNA with a preferred concentration of ~10-20 ng/µl, 1.5 µl of Ligation Buffer (330 mM Tris-acetate pH 7.5, 660 mM potassium acetate, 100 mM magnesium acetate, 5 mM DTT), 1.5 µl of 100 mM ATP and 1 µl DNA ligase.
6. Incubate the mixture for 15 min at room temperature, and then inactivate the enzyme by incubating for 15 min at 70 °C. (Note: Incubating the mixture at room temperature for longer may increase the success of the ligation).

4. Inverse PCR (iPCR) and Sequence Analysis

1. Perform iPCR on ligation product using the following forward and reverse primers and thermocycling conditions:
   -Forward Primer (Gm3OUT): GGGCATACGGGAAGAAGTGA
   -Reverse Primer (Gm5OUT): GACTGCCCTGCTGCGTAACA
   Thermocycler Conditions:
   1. 94 °C for 1 min.
   2. 94 °C for 1 min.
   3. 58 °C for 2 min.
   4. 72 °C for 2 min.
   5. 72 °C for 8 min.
   6. 10 °C hold.
   Repeat steps 2-4 for 34 cycles.
   (NOTE: Amplified iPCR products can be stored at 4 °C.)
2. Perform agarose gel electrophoresis to confirm successful iPCR amplification.
3. Perform sequencing on the iPCR product using the Gm3OUT and Gm5OUT primers. The insertion site and the orientation of himar1 are mapped out.

Results

As illustrated in Figure 1, the mini-himar1 mariner transposon vector, pFAC, contains two 27 bp inverted repeats with TA insertion sites flanking the aacC1 gentamycin resistance cassette, with its σ⁷⁰-dependent promoter, and a multiple cloning site (MCS). Additionally, the pFAC vector contains genes encoding the highly active himar1 transposase, β-lactamase (bla), and the tra transfer operon. The TA insertion sites allow for an efficient integration...

Discussion

It is important to note that this method can be used in other Pseudomonas species with these alterations: incubate P. fluorescens and P. putida at 30 °C, and P. stutzeri at 42 °C; P. stuzeri should be cultured on LB plates supplemented with 150 µg/mL of gentamycin; on step 1.11, P. stutzeri cells should be transferred into 500 µl of LB instead of 1 ml. Additionally, there are two critical steps for this protocol. First, the recipient strain should ...

Materials

List of materials used in this article

Name	Company	Catalog Number	Comments
Luria Broth	Difco	240230	via Fisher Scientific
Pseudomonas isolation agar	Difco	292710	via Fisher Scientific
Small Plates (100 O.D. x 10 mm)	Fisher Scientific	08-757-13
Large Plates (150 O.D. x 15 mm)	Fisher Scientific	08-757-14
Glycerol	Fisher Scientific	BP229-4
Benchtop Shaking Incubator	New Brunswick Scientific	Innova 4080	shake at 200 rpm
Cabinet Incubator	VWR	1540
Benchtop Microcentrifuge	Sorvall	75-003-287	via Fisher Scientific
SmartSpec Plus Spectrophotometer	Bio-Rad	170-2525	or preferred method/vendor
Diposable Inoculation Loops	Fisher Scientific	22-363-597
1.5 ml Microcentrifuge Tubes	Fisher Scientific	05-408-129
2.0 ml Cryogenic Vials	Corning	430659	via Fisher Scientific
15 ml Tubes	Fisher Scientific	05-539-12
Skim Milk	Difco	DF0032-17-3	via Fisher Scientific
DNeasy Blood and Tissue (250)	Qiagen	69506	or preferred method/vendor
QIAquick PCR Purification Kit (250)	Qiagen	28106	or preferred method/vendor
QIAprep Spin Miniprep Kit (250)	Qiagen	27106	or preferred method/vendor
FastLink II DNA Ligation Kit	Epicentre Technologies	LK6201H	via Fisher Scientific
Accu block Digital Dry Bath	Labnet	NC0205808	via Fisher Scientific
Sal1, restriction endonuclease	New England BioLabs	R0138L
EasyStart Micro 50	Molecular BioProducts	6020	via Fisher Scientific
Taq DNA Polymerase	New England BioLabs	M0267L
iCycler, Thermocycler	Bio-Rad	170-8740
LE agarose	Genemate	3120-500	via Fisher Scientific
Gentamycin Sulfate	Fisher Scientific	BP918-1
2.0 ml Cryogenic Vials	Corning	430659	via Fisher Scientific